Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " October 21, 2009":" November 20, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: MK0518 (Raltegravir);   Drug: famotidine;   Drug: omeprazole
22 Completed Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1
Condition: HIV-1 Infections
Intervention: Drug: BMS-663068 with or without ritonavir
23 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Conditions: HIV Infections;   H1N1 Influenza
Intervention: Biological: Arepanrix
24 Unknown  CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Condition: HIV-1 Infections
Interventions: Drug: IL-2 (~1.2M IU/m2);   Biological: T Cell infusion 5-10 x E9 T cells
25 Completed Managerial Database II
Condition: HIV
Intervention: Other: Observation
26 Completed
Has Results
Trichomonas Vaginalis Recurrence Among HIV+ Women
Conditions: Trichomonas Infections;   HIV Infections
Intervention: Drug: Metronidazole
27 Completed Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Conditions: Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
Intervention: Drug: Pegylated interferon alfa-2a and Ribavirin
28 Active, not recruiting Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Conditions: AIDS-Related Kaposi Sarcoma;   HIV Infection;   Recurrent Kaposi Sarcoma
Interventions: Drug: Bortezomib;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
29 Unknown  Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients
Conditions: HIV-1 Adults Patients;   AIDS;   Triple Class Failure
Interventions: Drug: maraviroc;   Drug: Raltegravir;   Drug: Darunavir/ritonavir
30 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Study has passed its completion date and status has not been verified in more than two years.